Applied Therapeutics WKN: A2PHHB ISIN: US03828A1016 Forum: Aktien Thema: Hauptdiskussion
Applied Therapeutics (Nasdaq: APLT) agreed to be acquired by Cycle Group Holdings for $0.088 per share cash plus one non-transferrable contingent value right (CVR). The CVR can pay up to $0.10 for FDA approval in a galactosemia indication, $0.10 for FDA approval in CMT-SORD, and $0.20 upon first worldwide net sales ≥ $200M in any four-quarter period; CVR holders also share in a capped Closing Cash Payment tied to Applied cash above $500,000 (capped at $1.5M). The tender offer is expected to close in Q1 2026; the merger has no financing condition. Applied received an unsecured promissory note enabling up to $8.5M in loans to fund working capital.
|
|
Thema | ||
|---|---|---|---|
| 1 | NVIDIA Hauptdiskussion | -3,52 % | |
| 2 | Canopy Hauptforum | +8,92 % | |
| 3 | RHEINMETALL Hauptdiskussion | +2,05 % | |
| 4 | Security der nächsten Generation | +9,63 % | |
| 5 | Quantum Emotion, redefrei | +9,63 % | |
| 6 | Dax Prognose | -0,71 % | |
| 7 | Tilray Brands Hauptforum | -5,33 % | |
| 8 | AVAGO TECHNOLOGIES LTD. REGISTERED SHARES O.N. Hauptdiskussion | -4,78 % | |
| 9 | ORACLE Hauptdiskussion | -5,26 % | |
| 10 | Strategy B | -2,20 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | NVIDIA Hauptdiskussion | -3,42 % | |
| 2 | Canopy Hauptforum | +7,69 % | |
| 3 | RHEINMETALL Hauptdiskussion | +2,04 % | |
| 4 | Security der nächsten Generation | +9,85 % | |
| 5 | Quantum Emotion, redefrei | +9,85 % | |
| 6 | Tilray Brands Hauptforum | -5,33 % | |
| 7 | AVAGO TECHNOLOGIES LTD. REGISTERED SHARES O.N. Hauptdiskussion | -4,98 % | |
| 8 | ORACLE Hauptdiskussion | -5,44 % | |
| 9 | BioNTech Hauptdiskussion | +0,57 % | |
| 10 | Strategy B | -2,17 % | Alle Diskussionen |